Belimumab Plus Standard Therapy Improves Renal Outcomes in Patients With Active Lupus Nephritis By Emily Pond
Study Supports Safety, Efficacy of Tofacitinib in the Treatment of Ankylosing Spondylitis By Emily Pond
Cross-Cutting Disease Factors Predictive of Mental Health in Youth With Rheumatologic Disease By Amit Akirov, MD
Comparative Performance of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes By Rheumatology Advisor Contributing Writer
Assessing the Long-Term Safety and Efficacy of Tocilizumab in Systemic Sclerosis By Rheumatology Advisor Contributing Writer
Low LDL Associated With Coronary Atherosclerosis Burden, CVD Risk in Non-Obese Patients With RA By Florence Chaverneff, PhD
Avacopan Superior to Standard Therapy in Renal Function in ANCA-Associated Vasculitis By Amit Akirov, MD
Healthcare Providers Recognize Potential Benefits of Telemedicine in Pediatric Rheumatology During the COVID-19 Pandemic By Sabrina Mammen